22 days ago
VRTX
AnalystsJoon LeeJoon Lee's Stock Forecasts
AnalystsJoon Lee
Sectors:
Analyst Ranking
Top 2%
#68 out of 5232 analysts
Average Return
+42.83%
Win Rate
60%80 out of 134
Risk vs Reward
Poor
Good
Joon Lee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +885.37% | $33.55 | $330.59 | 2025-03-03 - 2026-03-02 | Strong Buy |
Verona Pharma PLCVRNA | +548.82% | $14.46 | $93.82 | 2024-06-28 - 2025-06-27 | Strong Buy |
Viking Therapeutics IncVKTX | +470.38% | $10.87 | $62.00 | 2023-10-02 - 2024-10-01 | Strong Buy |
Intellia Therapeutics IncNTLA | +418.87% | $25.44 | $132.00 | 2020-10-27 - 2021-10-26 | Strong Buy |
Viking Therapeutics IncVKTX | +414.75% | $15.93 | $82.00 | 2023-03-29 - 2024-03-28 | Strong Buy |
Joon Lee Analyst Color
Get additional color on Joon Lee's coverage of popular stocks
a month ago
PRAX
3 months ago
JAZZ
3 months ago
BMRN
4 months ago
WVE
4 months ago
PRAX
5 months ago
ALKS
5 months ago
BMRN
6 months ago
PRAX
7 months ago
ARGX
7 months ago
JAZZ
8 months ago
PTCT
a year ago
CORT
a year ago
AXSM
a year ago
CRSP
a year ago
AXSM
a year ago
ARGX
a year ago
AXSM
a year ago
VRNA
a year ago
WVE
a year ago
CPRX
a year ago
ARGX
a year ago
CRMD
a year ago
VRNA
2 years ago
CORT
Joon Lee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $525.00 | +17.57% | Maintains | 22 days ago |
Praxis Precision Medicines IncPRAX | 8 | Strong Buy | $700.00 | +117.26% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 4 | Strong Buy | $230.00 | +21.66% | Maintains | 3 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $100.00 | +77.02% | Maintains | 3 months ago |
Wave Life Sciences LtdWVE | 4 | Strong Buy | $50.00 | +589.66% | Maintains | 4 months ago |
Alkermes PLCALKS | 3 | Strong Buy | $55.00 | +55.54% | Maintains | 5 months ago |
Intellia Therapeutics IncNTLA | 5 | Strong Buy | $14.00 | +9.20% | Reiterates | 5 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Strong Buy | $90.00 | +329.59% | Maintains | 5 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $44.00 | +40.62% | Initiates Coverage On | 7 months ago |
Argenx SeARGX | 13 | Strong Buy | $918.00 | +25.71% | Maintains | 7 months ago |
Ptc Therapeutics IncPTCT | 2 | Strong Buy | $86.00 | +26.23% | Maintains | 8 months ago |
Sage Therapeutics IncSAGE | 8 | Hold | $9.00 | +3.69% | Maintains | 10 months ago |
Viking Therapeutics IncVKTX | 8 | Strong Buy | $75.00 | +130.49% | Reiterates | a year ago |
Arvinas IncARVN | 6 | Strong Buy | $21.00 | +98.11% | Maintains | a year ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $150.00 | N/A | Maintains | a year ago |
Axsome Therapeutics IncAXSM | 5 | Strong Buy | $200.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 5 | Strong Buy | $120.00 | N/A | Maintains | a year ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Verona Pharma PLCVRNA | 6 | Strong Buy | $57.00 | N/A | Reiterates | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | a year ago |
Catalyst Pharmaceuticals IncCPRX | 7 | Strong Buy | $36.00 | N/A | Maintains | a year ago |
Editas Medicine IncEDIT | 7 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Strong Buy | $17.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 2 | Hold | $60.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 6 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 7 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Taysha Gene Therapies IncTSHA | 7 | Strong Buy | $5.00 | N/A | Maintains | 3 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Concert Pharmaceuticals IncCNCE | 2 | Strong Buy | $25.00 | N/A | Maintains | 4 years ago |
Aptinyx IncAPTX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Cyclerion Therapeutics IncCYCN | 1 | Strong Buy | $280.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $50.00 | N/A | Upgrades | 5 years ago |
Translate Bio IncTBIO1 | 2 | Hold | $360.00 | N/A | Downgrades | 5 years ago |
Anaptysbio IncANAB | 1 | Strong Buy | $34.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.